Albemarle Stock

$81.05

7.38% today

NYSE, Aug 11, 04:16 pm CET

ISIN

US0126531013

Symbol

ALB

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Materials

Industry

Chemicals

Overview Dividends Analysts Charts News Strategies

Albemarle Stock price

$75.48

-11.74 13.46% 5Y

NYSE, Closing price Fri, Aug 08 2025

+5.42 7.74%

ISIN

US0126531013

Symbol

ALB

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Materials

Industry

Chemicals

Key metrics

Basic

Market capitalization

$8.9b

Enterprise Value

$10.7b

Net debt

$1.8b

Cash

$1.8b

Shares outstanding

117.7m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

1.8 | 1.8

EV/Sales

2.1 | 2.2

EV/FCF

negative

P/B

0.9

Dividends

DPS

$1.61

Yield 1Y | 5Y

2.1% | 1.0%

Growth 1Y | 5Y

0.6% | 1.8%

Payout 1Y | 3Y

-14.4% | 19.2%

Increased

25 Years

Financials (TTM | estimate)

Revenue

$5.0b | $4.9b

EBITDA

$426.2m | $966.8m

EBIT

$-230.9m | $-47.9m

Net Income

$-1.1b | $-182.4m

Free Cash Flow

$-181.7m

Growth (TTM | estimate)

Revenue

-33.1% | -9.3%

EBITDA

167.7% | 2,477.2%

EBIT

79.8% | 92.4%

Net Income

-97.8% | 86.1%

Free Cash Flow

85.6%

Financial Health

Equity Ratio

60.0%

Return on Equity

-13.2%

ROCE

-1.5%

ROIC

-1.8%

Debt/Equity

0.4

EPS

$-9.3

FCF per Share

$-1.5

Short interest

18.9%

Employees

Rev per Employee

$650.0k

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Get Started for Free Today

Albemarle Stock Analysis

Unlock Scores for Free

??

32 Analysts have issued a Albemarle forecast:

12x Buy

38%

16x Hold

50%

More details on Analyst Estimates Including Price Targets

32 Analysts have issued a Albemarle forecast:

Buy

38%

Hold

50%

Sell

13%

Analyst Estimates with Stock Price Targets

Financial data from Albemarle

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	4,993 4,993	33% 33% 100%
- Direct Costs	4,606 4,606	43% 43% 92%
Gross Profit	387 387	164% 164% 8%
- Selling and Administrative Expenses	549 549	24% 24% 11%
- Research and Development Expense	69 69	22% 22% 1%
EBITDA	426 426	168% 168% 9%
- Depreciation and Amortization	657 657	28% 28% 13%
EBIT (Operating Income) EBIT	-231 -231	80% 80% -5%
Net Profit	-1,096 -1,096	98% 98% -22%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Albemarle Stock News

Positive

CNBC

●

about 2 hours ago

Lithium stocks surge after Chinese mine suspends production

Albemarle and the Sprott Lithium Miners ETF are rallying after a key mine in China suspended lithium production. The balance between lithium supply and demand was already tightening, with a small surplus expected in 2025, according to Morgan Stanley.

Neutral

The Motley Fool

●

11 days ago

Albemarle (ALB) Q2 Revenue Jumps

Positive

Proactive Investors

●

11 days ago

Albemarle posts surprise Q2 profit on lithium demand

Albemarle Corporation (NYSE:ALB, ETR:AMC) reported an unexpected second-quarter profit on Thursday, as steady demand for lithium used in electric vehicles and energy storage helped offset a volatile pricing environment. The US-based lithium producer posted adjusted earnings of $0.11 per share, beating analysts' expectations of a $0.78 loss.

More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office	United States
CEO	Jerry Masters
Employees	8,300
Founded	1993
Website	www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now